LOW vs NRIX · P/E 18, rev $86.29B vs rev $54.5M
Lowe's Companies Inc (LOW) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
LOW currently screens at market cap $121.89B and trailing P/E 18.4. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the LOW and NRIX stock pages for the full models.
Not investment advice.